首页> 外文期刊>PLoS One >Generation of a protective murine monoclonal antibody against the stem of influenza hemagglutinins from group 1 viruses and identification of resistance mutations against it
【24h】

Generation of a protective murine monoclonal antibody against the stem of influenza hemagglutinins from group 1 viruses and identification of resistance mutations against it

机译:从第1组病毒生成血流感血凝素茎的保护鼠单克隆抗体,并鉴定抗抗抗损伤

获取原文
获取外文期刊封面目录资料

摘要

Vaccines that elicit broadly cross-neutralizing antibodies, including antibodies that target the conserved stem of hemagglutinin (HA), are being developed as a strategy for next-generation influenza vaccines that protect against influenza across multiple years. However, efficient induction of cross-neutralizing antibodies remains a challenge, and potential escape mutations have not been well characterized. Here we elicited cross-neutralizing antibodies by immunizing animals with the hemagglutinins from H5 and H9 subtype influenza A viruses that are sensitive to neutralization by stem antibodies. We further isolated and characterized an HA stem monoclonal antibody 4C2 that broadly neutralizes group 1 influenza viruses and identified HA mutations that reduced sensitivity to stem antibodies. Our results offer insights for next-generation influenza vaccine strategies for inducing cross-neutralizing antibodies.
机译:引发广泛交叉中和抗体的疫苗,包括靶向血凝素(HA)保守源(HA)的抗体,作为下一代流感疫苗的策略,这些疫苗在多年来保护患病率。 然而,有效的交叉中和抗体诱导仍然是一个挑战,并且潜在的逃逸突变并未具体表征。 在这里,我们通过用H5和H9亚型流感的血凝素免疫动物来引发交叉中和抗体,该血液凝集素流感对茎抗体对中和敏感的病毒。 我们进一步分离和表征了HA茎单克隆抗体4C2,其广泛中和第1组流感病毒并确定了对茎抗体敏感性的敏感性的HA突变。 我们的结果为下一代流感疫苗策略提供了诱导交叉中和抗体的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号